Page last updated: 2024-08-22

tiletamine hydrochloride and Chromosomal Translocation

tiletamine hydrochloride has been researched along with Chromosomal Translocation in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dewan, MZ; Higashihara, M; Honda, M; Horie, R; Itoh, K; Mizoguchi, H; Okamura, T; Sasaki, M; Sata, T; Umezawa, K; Watanabe, M; Watanabe, T; Yamamoto, N	1
Kubota, T; Miyasaka, N; Nanki, T; Umezawa, K; Wakamatsu, K	1

Other Studies

2 other study(ies) available for tiletamine hydrochloride and Chromosomal Translocation

Article	Year
A novel NF-kappaB inhibitor DHMEQ selectively targets constitutive NF-kappaB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo. International journal of cancer, 2005, Mar-10, Volume: 114, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-X Protein; Benzamides; Calcium-Binding Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Line, Tumor; Cyclin D; Cyclin D1; Cyclins; Cyclohexanones; Disease Models, Animal; Down-Regulation; Enzyme Activation; Humans; Intracellular Signaling Peptides and Proteins; Membrane Glycoproteins; Mice; Mice, Inbred NOD; Mice, SCID; Multiple Myeloma; Nerve Tissue Proteins; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Synaptotagmin I; Synaptotagmins; Translocation, Genetic; Vascular Endothelial Growth Factor A	2005
Effect of a small molecule inhibitor of nuclear factor-kappaB nuclear translocation in a murine model of arthritis and cultured human synovial cells. Arthritis research & therapy, 2005, Volume: 7, Issue:6 Topics: Animals; Arthritis, Experimental; Benzamides; Cell Nucleus; Cell Proliferation; Cells, Cultured; Cyclohexanones; Disease Models, Animal; Hindlimb; Humans; Injections, Subcutaneous; Male; Mice; Mice, Inbred DBA; NF-kappa B; RNA, Messenger; Synovial Membrane; Translocation, Genetic	2005

Article

Year

A novel NF-kappaB inhibitor DHMEQ selectively targets constitutive NF-kappaB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo.

International journal of cancer, 2005, Mar-10, Volume: 114, Issue:1

Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-X Protein; Benzamides; Calcium-Binding Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Line, Tumor; Cyclin D; Cyclin D1; Cyclins; Cyclohexanones; Disease Models, Animal; Down-Regulation; Enzyme Activation; Humans; Intracellular Signaling Peptides and Proteins; Membrane Glycoproteins; Mice; Mice, Inbred NOD; Mice, SCID; Multiple Myeloma; Nerve Tissue Proteins; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Synaptotagmin I; Synaptotagmins; Translocation, Genetic; Vascular Endothelial Growth Factor A

2005

Effect of a small molecule inhibitor of nuclear factor-kappaB nuclear translocation in a murine model of arthritis and cultured human synovial cells.

Arthritis research & therapy, 2005, Volume: 7, Issue:6

Topics: Animals; Arthritis, Experimental; Benzamides; Cell Nucleus; Cell Proliferation; Cells, Cultured; Cyclohexanones; Disease Models, Animal; Hindlimb; Humans; Injections, Subcutaneous; Male; Mice; Mice, Inbred DBA; NF-kappa B; RNA, Messenger; Synovial Membrane; Translocation, Genetic

2005